OPA1 and Parkinson disease: The main pathological features, such as mitochondrial network fragmentation and reduced energetic capacity, have been also reproduced in induced pluripotent stem cell (iPSC)-derived dopaminergic neurons from patients carrying OPA1 mutations associated with Parkinsonism and DOA [90,91].